asthenia


Also found in: Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to asthenia: neurocirculatory asthenia

as·the·ni·a

 (ăs-thē′nē-ə)
n.
Loss or lack of bodily strength; weakness; debility.

[New Latin, from Greek astheneia, from asthenēs, weak : a-, without; see a-1 + sthenos, strength; see segh- in Indo-European roots.]

asthenia

(æsˈθiːnɪə) or

astheny

n
(Pathology) pathol an abnormal loss of strength; debility
[C19: via New Latin from Greek astheneia weakness, from a-1 + sthenos strength]

as•the•ni•a

(æsˈθi ni ə)

n.
lack or loss of strength; weakness.
[1795–1805; < Greek asthéneia=asthene-, s. of asthenḗs weak]

asthenia

Medicine. any of several conditions characterized by lack or loss of strength and energy, as neurasthenia, myasthenia, or somasthenia. — asthenie, adj.
See also: Strength and Weakness
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.asthenia - an abnormal loss of strengthasthenia - an abnormal loss of strength  
debility, feebleness, frailness, frailty, infirmity, valetudinarianism - the state of being weak in health or body (especially from old age)
Translations
astenijaslabost

as·the·ni·a

n. astenia, pérdida de vigor.

asthenia

n (ant) astenia
References in periodicals archive ?
A 20-year-old woman, with no history of medical problems, was admitted to the hospital on February 4, 2002, with a 3-week history of asthenia, myalgia, low-grade fever, urinary retention, and blurred vision.
In these patients, the most frequent clinical adverse experiences are dizziness, dyspnea, chest pain, asthenia, cough, diarrhea, and hypotension.
Other common adverse reactions included anemia, asthenia, diarrhea, ocular/visual disturbances, fluid retention, alopecia, hepatic dysfunction, mucositis, and renal dysfunction.
Moderate to severe adverse events occurring in more than 5 percent of patients receiving Viread included rash (rash, pruritis, maculopapular rash, urticaria, vesiculobullous rash and pustular rash), headache, pain, diarrhea, depression, back pain, fever, nausea, abdominal pain, asthenia and anxiety (Study 903).
The most common adverse effects causing patients to discontinue medication in clinical trials include, fatigue (4 percent), bradycardia (slow heartbeat -- 3 percent), dyspnea (labored breathing -- 3 percent), proarrhythmia (potential for a drug to induce an arrhythmia -- 3 percent), asthenia (weakness -- 2 percent) and dizziness (2 per.
The most common adverse events in this study possibly related to Dacogen were myelosuppression, fatigue, nausea, asthenia, dyspnea, diarrhea, and pneumonia.
At lesser frequencies by chills, nausea, vomiting, headache, urinary frequency, rhinitis, dizziness, vasodilation, lacrimation, asthenia, diarrhea and dyspepsia have been documented.
The most common (]greater than or equal to] 10%) adverse events observed in clinical trials of FENTORA were nausea, vomiting, application site abnormalities, fatigue, anemia, dizziness, constipation, edema, asthenia, dehydration, and headache.
Adverse events related to CINTREDEKIN BESUDOTOX or catheter placement were consistent with adverse events observed in Phase 1 studies of CINTREDEKIN BESUDOTOX administered as monotherapy in patients with recurrent malignant glioma and, regardless of causality, included asthenia, headache, alopecia, and nausea.